MyoKardia Announces Appointment of Cynthia Ladd as General Counsel

SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular disease... Biopharmaceuticals, Cardiology, Personnel MyoKardia, cardiomyopathy, mavacamten
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news